Actualités et Activités de Jaguar Animal Health
Dirigeants
Voir l'organigramme avec ses 26 principaux dirigeants
Biographies les plus recherchées chez Jaguar Animal Health
- Lisa Conte, Chief Executive Officer, Executive Director
- John Micek, Director
- James Bochnowski, Chairman of the Board
Créer une alerte
pour suivre les mouvements de dirigeants chez Jaguar Animal Health.
Pharmacie
Jaguar Animal Health a 1 825 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Eli Lilly (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- Chimerix and Chimerix have merged (publié le 22 avril 2025)..
- Imbria Pharmaceuticals vient d'annoncer une levée de fonds de 58 millions de dollars. (publié le 10 avril 2025).
- Clario a acquis NRx Pharmaceuticals (publié le 18 mars 2025).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par Jaguar Animal Health
- Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
- Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
- Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Jaguar Health, Inc.
- Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
- Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
- Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
- Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders | Jaguar Health, Inc.
- Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
- Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
- Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Jaguar Animal Health
- Jaguar Animal Health sur Wikipédia, Google News & Yahoo Finance en 1-click
- Jaguar Animal Health sur LinkedIn, Twitter & YouTube en 1-click
